Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ludmila Šebejová
Observed names:
L. Sebejova,
Ludmila Sebejova
Institution:
Masaryk University
Observed institutions:
Central European Institute of Technology,
Masaryk University,
Central European Institute of Technology – Masaryk University,
University Hospital Brno,
RECETOX,
Central European Institute of Technology
show all 6
OpenAlex ID:
A5087869216
Missense Mutations Located in Structural p53 DNA-Binding Motifs Are Associated With Extremely Poor Survival in Chronic Lymphocytic Leukemia
2011
·
Martin Trbusek
, Jana Smardova
, et al.
·
Journal of Clinical Oncology
·
86
PDF
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin
2013
·
V. Navrkalova
, L. Sebejova
, et al.
·
Haematologica
·
41
PDF
The exposure of Czech firefighters to perfluoroalkyl substances and polycyclic aromatic hydrocarbons: CELSPAC – FIREexpo case-control human biomonitoring study
2023
·
Katarína Řiháčková
, Aleš Pindur
, et al.
·
The Science of The Total Environment
·
28
PDF
Longitudinal study of epigenetic aging and its relationship with brain aging and cognitive skills in young adulthood
2023
·
Klara Mareckova
, Anna Pacinkova
, et al.
·
Frontiers in Aging Neuroscience
·
23
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study
2015
·
Michael Doubek
, Yvona Brychtova
, et al.
·
American Journal of Hematology
·
23
PDF
Distinct cellular responses to replication stress leading to apoptosis or senescence
2019
·
Emilie Lukášová
, Martina Řezáčová
, et al.
·
FEBS Open Bio
·
17
PDF
Human biomonitoring of essential and toxic trace elements (heavy metals and metalloids) in urine of children, teenagers, and young adults from a Central European Cohort in the Czech Republic
2024
·
Brij Mohan Sharma
, Klára Komprdová
, et al.
·
Journal of Exposure Science & Environmental Epidemiology
·
16
Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab
2014
·
Ludmila Sebejova
, Marek Borsky
, et al.
·
Experimental Hematology
·
10
PDF
Exposure to benzotriazoles and benzothiazoles in Czech male population and its associations with biomarkers of liver function, serum lipids and oxidative stress
2024
·
Nina Pálešová
, Lucie Bláhová
, et al.
·
International Archives of Occupational and Environmental Health
·
9
PDF
Internal Flames: Metal(loid) Exposure Linked to Alteration of the Lipid Profile in Czech Male Firefighters (CELSPAC-FIREexpo Study)
2024
·
Nina Pálešová
, Katarína Řiháčková
, et al.
·
Environmental Science & Technology Letters
·
5
The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells
2013
·
Veronika Navrkalova
, Ludmila Sebejova
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
5
Ofatumumab Added To Dexamethasone In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia. Results From a Phase II Study Of The Czech Leukemia Study Group For Life
2013
·
Michael Doubek
, Yvona Brychtova
, et al.
·
Blood
·
3
Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia
2012
·
Michael Doubek
, Martin Trbušek
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
3
TheBCR–ABL1T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy
2013
·
Jitka Malcikova
, Filip Razga
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
2
Deep sequencing identifies TP53 mutations before their clonal selection by therapy in chronic lymphocytic leukemia
2012
·
Martin Trbušek
, Kateřina Staňo Kozubík
, et al.
·
2
Cohort profile: The Czech Health, Alcohol and Psychosocial factors In Eastern Europe study (HAPIEE-CZ)
2026
·
Andrea Dalecká
, Anne Peasey
, et al.
·
Research Square
·
1
PDF
Sada pro detekci přítomnosti mutací v genu ATM u pacientů s CLL
2017
·
Martin Trbušek
, Zuzana Jašková
, et al.
Indukce buněčné smrti u vysoce rizikových kultur chronické lymfocytární leukémie pomocí monoklonálních protilátek
2015
·
Ludmila Šebejová
Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase
2015
·
Jana Zemanová
, Kamil Paruch
, et al.
Mutační a funkční analýza genu ATM u pacientů s chronickou lymfocytární leukémií
2015
·
Veronika Navrkalová
, Jana Zemanová
, et al.
Is checkpoint kinase 1 a suitable molecular target for combination with cancer chemotherapeutics
2014
·
Jana Zemanová
, Ludmila Šebejová
, et al.
Reactivation of mutated p53 in chronic lymphocytic leukemiacells using prima-1 met.
2014
·
Zuzana Jašková
, Ludmila Šebejová
, et al.
Is checkpoint kinase 1 a suitable molecular target forsensitization of TP53-mutated leukemia and lymphoma cells tochemotherapy?
2014
·
Jana Zemanová
, Ludmila Šebejová
, et al.
SF3B1 Mutations Frequently Occur With Both ATM Mutations and TP53 Mutations In CLL Patients
2013
·
Veronika Navrkalova
, Jitka Malcikova
, et al.
·
Blood
Clonal Evolution and Therapy Related Selection Of TP53 Mutations In Chronic Lymphocytic Leukemia Patients
2013
·
Karla Plevova
, Jitka Malcikova
, et al.
·
Blood
Show more works
View as search
Works count:
62
Citation count:
274
H-index:
9
I10-index:
8
Year
Topic
Type